Cowealth Medical Holding Co., Ltd.(TW:4745)
NT$10.30-0.05 (-0.48%)
TW:4745
Cowealth Medical Holding Co., Ltd. financials statements
NT$10.30
At close:-0.05 (-0.48%)
Cowealth Medical Holding Co., Ltd. (4745) Ratios
Cowealth Medical Holding Co., Ltd. Ratios
TW:4745's free cash flow for Q2 2026 was NT$347.01M. For the 2026 fiscal year, TW:4745's free cash flow was decreased by NT$-3.70M and operating cash flow was NT$350.71M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Jun 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.79 | 3.39 | 3.61 | 3.34 | 2.75 |
| Quick Ratio | 2.41 | 2.88 | 3.08 | 2.87 | 2.30 |
| Cash Ratio | 0.48 | 0.67 | 0.53 | 0.72 | 0.49 |
| Solvency Ratio | -0.10 | 0.03 | 0.07 | 0.08 | 0.11 |
| Operating Cash Flow Ratio | 0.01 | 0.21 | 0.03 | -0.14 | -0.07 |
| Short-Term Operating Cash Flow Coverage | 0.02 | 0.43 | 0.07 | -0.31 | -0.15 |
| Net Current Asset Value | NT$ 3.53B | NT$ 4.18B | NT$ 4.06B | NT$ 4.42B | NT$ 2.85B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.14 | 0.13 | 0.10 | 0.13 | 0.17 |
| Debt-to-Equity Ratio | 0.35 | 0.31 | 0.24 | 0.34 | 0.36 |
| Debt-to-Capital Ratio | 0.26 | 0.24 | 0.19 | 0.25 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.02 | 0.02 |
| Financial Leverage Ratio | 2.45 | 2.49 | 2.44 | 2.54 | 2.10 |
| Debt Service Coverage Ratio | -0.27 | 0.14 | 0.37 | 0.36 | 0.37 |
| Interest Coverage Ratio | -12.12 | 3.15 | 7.95 | 14.81 | 13.98 |
| Debt to Market Cap | 0.51 | 0.67 | 0.31 | 0.48 | 0.42 |
| Interest Debt Per Share | 13.30 | 14.33 | 8.80 | 12.67 | 12.11 |
| Net Debt to EBITDA | -0.29 | -1.84 | -0.52 | -0.91 | 0.16 |
| Profitability Margins | |||||
| Gross Profit Margin | 11.95% | 18.88% | 20.71% | 19.63% | 20.58% |
| EBIT Margin | -9.32% | 2.81% | 6.34% | 7.35% | 6.99% |
| EBITDA Margin | -7.62% | 4.01% | 7.47% | 8.36% | 8.35% |
| Operating Profit Margin | -9.32% | 2.17% | 5.74% | 6.57% | 6.63% |
| Pretax Profit Margin | -9.65% | 2.12% | 5.62% | 6.90% | 6.51% |
| Net Profit Margin | -8.34% | 0.02% | 1.16% | 1.67% | 2.71% |
| Continuous Operations Profit Margin | -11.20% | 1.14% | 2.87% | 4.18% | 4.20% |
| Net Income Per EBT | 86.42% | 0.71% | 20.61% | 24.24% | 41.66% |
| EBT Per EBIT | 103.58% | 97.68% | 97.88% | 105.01% | 98.17% |
| Return on Assets (ROA) | -3.50% | 0.01% | 0.84% | 1.31% | 2.58% |
| Return on Equity (ROE) | -8.59% | 0.02% | 2.05% | 3.32% | 5.43% |
| Return on Capital Employed (ROCE) | -5.44% | 1.75% | 5.45% | 7.00% | 9.26% |
| Return on Invested Capital (ROIC) | -4.54% | 0.81% | 2.70% | 3.63% | 4.88% |
| Return on Tangible Assets | -3.52% | 0.01% | 0.84% | 1.31% | 2.58% |
| Earnings Yield | -12.54% | 0.05% | 2.79% | 4.89% | 6.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.92 | 1.23 | 1.43 | 1.66 | 1.97 |
| Payables Turnover | 3.71 | 4.94 | 5.28 | 5.73 | 7.35 |
| Inventory Turnover | 3.46 | 3.79 | 4.55 | 5.03 | 5.29 |
| Fixed Asset Turnover | 4.27 | 7.69 | 9.25 | 15.45 | 13.33 |
| Asset Turnover | 0.42 | 0.60 | 0.73 | 0.78 | 0.95 |
| Working Capital Turnover Ratio | 0.76 | 1.01 | 1.12 | 1.50 | 1.74 |
| Cash Conversion Cycle | 404.63 | 318.13 | 265.75 | 228.51 | 204.92 |
| Days of Sales Outstanding | 397.42 | 295.76 | 254.70 | 219.68 | 185.63 |
| Days of Inventory Outstanding | 105.63 | 96.24 | 80.25 | 72.53 | 68.94 |
| Days of Payables Outstanding | 98.41 | 73.87 | 69.19 | 63.70 | 49.65 |
| Operating Cycle | 503.05 | 392.00 | 334.95 | 292.21 | 254.57 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.20 | 5.95 | 0.58 | -3.46 | -1.53 |
| Free Cash Flow Per Share | 0.01 | 5.03 | -2.47 | -3.80 | -2.00 |
| Dividend Paid and CapEx Coverage Ratio | 1.06 | 4.23 | 0.12 | -1.88 | -0.91 |
| Capital Expenditure Coverage Ratio | 1.06 | 6.51 | 0.19 | -10.15 | -3.23 |
| Operating Cash Flow Coverage Ratio | 0.02 | 0.43 | 0.07 | -0.28 | -0.13 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.09 | 0.01 | -0.05 | -0.02 |
| Free Cash Flow Yield | 0.04% | 24.61% | -9.60% | -15.27% | -7.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.97 | 2045.00 | 35.76 | 20.37 | 14.78 |
| Price-to-Sales (P/S) Ratio | 0.66 | 0.31 | 0.41 | 0.34 | 0.40 |
| Price-to-Book (P/B) Ratio | 0.68 | 0.46 | 0.73 | 0.68 | 0.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 2351.06 | 4.06 | -10.42 | -6.55 | -13.29 |
| Price-to-Operating Cash Flow Ratio | 126.56 | 3.44 | 44.31 | -7.19 | -17.40 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -20.74 | -0.87 | -0.63 | 1.25 |
| Enterprise Value Multiple | -9.01 | 5.81 | 5.03 | 3.18 | 4.97 |
| Enterprise Value | 2.03B | 976.17M | 1.81B | 1.50B | 2.13B |
| EV to EBITDA | -9.01 | 5.81 | 5.03 | 3.18 | 4.97 |
| EV to Sales | 0.69 | 0.23 | 0.38 | 0.27 | 0.41 |
| EV to Free Cash Flow | 2428.41 | 3.08 | -9.44 | -5.09 | -13.74 |
| EV to Operating Cash Flow | 130.72 | 2.61 | 40.15 | -5.60 | -18.00 |
| Tangible Book Value Per Share | 64.81 | 82.05 | 64.47 | 67.06 | 45.46 |
| Shareholders’ Equity Per Share | 37.02 | 44.50 | 35.09 | 36.61 | 33.15 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.16 | 0.46 | 0.44 | 0.39 | 0.35 |
| Revenue Per Share | 38.13 | 66.66 | 62.12 | 72.65 | 66.36 |
| Net Income Per Share | -3.18 | 0.01 | 0.72 | 1.22 | 1.80 |
| Tax Burden | 0.86 | 0.01 | 0.21 | 0.24 | 0.42 |
| Interest Burden | 1.04 | 0.75 | 0.89 | 0.94 | 0.93 |
| Research & Development to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.19 | 0.16 | 0.14 | 0.12 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.05 | 4.21 | 0.81 | -2.84 | -0.85 |
Currency in TWD
